Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 7 analysts offering 12 month price targets for Immuneering Corp have a median target of 12.00, with a high estimate of 25.00 and a low estimate of 1.50. The median estimate represents a 395.87% increase from the last price of 2.42.
High | 933.1% | 25.00 |
Med | 395.9% | 12.00 |
Low | -38.0% | 1.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | -2.77% |
Average growth rate | +11.96% |
More ▼
Revenue history & estimates in USD
Average growth rate | 0.00% |
Average growth rate | -92.38% |
More ▼